自噬调节阿尔茨海默病中Tau蛋白代谢
Autophagy Regulates Tau Protein Metabolism in Alzheimer’s Disease
DOI: 10.12677/ACM.2023.1361387, PDF,    国家自然科学基金支持
作者: 夏伟壮*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;李虹霖#:黑龙江中医药大学研究生院,黑龙江 哈尔滨;黑龙江中医药大学附属第二医院,黑龙江 哈尔滨
关键词: 阿尔茨海默病细胞自噬Tau蛋白自噬调节剂Alzheimer’s Disease Autophagy Tau Protein Autophagy Modulators
摘要: 阿尔茨海默病(Alzheimer’s disease, AD)是一种以进行性认知和行为功能障碍为主要特征的中枢神经系统退行性病变,异常磷酸化的Tau蛋白积聚形成的神经纤维缠结(Neurofibrillary tangles, NFTs)被认为是其中最主要的致病因素之一。目前,临床中用于治疗AD的大多数药物只能改善疾病的基本症状,无法从根本上阻止疾病病理过程的进展。自噬作为真核细胞中物质降解的一个重要方式,在维持内环境稳态的方面发挥着至关重要的作用。自噬调节可能是AD的一种治疗策略,也可能是延缓其进展的一种方法。本文旨在探讨自噬参与阿尔茨海默病中Tau蛋白的降解,调节自噬来减少Tau蛋白的累积从而来治疗AD,可能为今后AD的治疗提供一种的新思路。
Abstract: Alzheimer’s disease is a degenerative disease of the central nervous system characterized by pro-gressive cognitive and behavioral dysfunction. The neurofibrillary tangles formed by the accumula-tion of abnormally phosphorylated tau protein are considered to be one of the most important pathogenic factors. At present, most drugs used to treat AD in clinic can only improve the basic symptoms of the disease, but can’t fundamentally stop the progress of the pathological process of the disease. Autophagy, as an important way of substance degradation in eukaryotic cells, plays a vital role in maintaining the homeostasis of internal environment. Autophagy regulation may be a therapeutic strategy for AD or a method to delay its progress. This paper aims to explore the in-volvement of autophagy in the degradation of tau in Alzheimer’s disease and regulate autophagy to reduce the accumulation of tau protein to treat AD, which may provide a new treatment idea in the future.
文章引用:夏伟壮, 李虹霖. 自噬调节阿尔茨海默病中Tau蛋白代谢[J]. 临床医学进展, 2023, 13(6): 9923-9929. https://doi.org/10.12677/ACM.2023.1361387

参考文献

[1] 刘兴媛. 电针通过长非编码RNA SNHG1调控细胞自噬、糖代谢和铁死亡延缓阿尔茨海默病进展及机制研究[D]: [博士学位论文]. 南昌: 南昌大学, 2021.
[2] 毕鸿昊, 郭惠怡, 陈强. 自噬与炎症小体相互作用对干性年龄相关性黄斑变性影响的研究进展[J]. 中国中医眼科杂志, 2022, 32(6): 482-486.
[3] 张鑫, 黎萍, 王钰涵, 郑彩平, 邓小艳, 齐路明, 李涓, 江一静, 夏丽娜. 血管性痴呆认知功能障碍与海马线粒体功能异常的机制研究进展[J]. 中国全科医学, 2022, 25(23): 2910-2916.
[4] Chang, C.W., Shao, E. and Mucke, L. (2021) Tau: Enabler of Diverse Brain Disorders and Target of Rapidly Evolving Therapeutic Strategies. Science, 371, eabb8255. [Google Scholar] [CrossRef] [PubMed]
[5] Ji, C., Tang, M., Zeidler, C., Höhfeld, J. and Johnson, G.V. (2019) BAG3 and SYNPO (Synaptopodin) Facilitate Phospho-MAPT/Tau Degradation via Autophagy in Neuronal Processes. Autophagy, 15, 1199-1213. [Google Scholar] [CrossRef] [PubMed]
[6] 芦亚飞. 抑制tau蛋白聚集的化合物筛选及分子作用机制研究[D]: [硕士学位论文]. 深圳: 深圳大学, 2020.
[7] 田一虹. 远志皂苷元减轻Aβ1-42致神经元损伤的机制: 线粒体自噬途径研究[D]: [博士学位论文]. 兰州: 兰州大学, 2022.[CrossRef
[8] 吕燕, 吴林, 陈炜, 黄晓丹, 刘璐, 李兴锋, 陈业文. 自噬在阿尔茨海默病中作用机制的研究进展[J]. 广西医学, 2019, 41(10): 1286-1289+1292.
[9] Nixon, R.A. (2013) The Role of Autophagy in Neurodegenerative Disease. Nature Medicine, 19, 983-997. [Google Scholar] [CrossRef] [PubMed]
[10] 巩卓彦. 半夏泻心汤对APP/PS1双转基因小鼠海马神经元早期自噬影响[D]: [硕士学位论文]. 北京: 北京中医药大学, 2021.
[11] Feng, Q., Luo, Y., Zhang, X.N., et al. (2020) MAPT/Tau Accumulation Represses Autophagy Flux by Disrupting IST1-Regulated ESCRT-III Complex Formation: A Vicious Cycle in Alzheimer Neurodegeneration. Autophagy, 16, 641-658. [Google Scholar] [CrossRef] [PubMed]
[12] Chambraud, B., Daguinot, C., Guillemeau, K., et al. (2021) Decrease of Neuronal FKBP4/FKBP52 Modulates Perinuclear Lysosomal Positioning and MAPT/Tau Behavior during MAPT/Tau-Induced Proteotoxic Stress. Autophagy, 17, 3491-3510. [Google Scholar] [CrossRef] [PubMed]
[13] 周艳, 储丹丹. 阿尔茨海默病中tau蛋白的病理改变与治疗策略[J]. 南通大学学报(医学版), 2021, 41(3): 245-250.
[14] Metcalfe, M.J., Huang, Q. and Figueiredo-Pereira, M.E. (2012) Coordination between Proteasome Impairment and Caspase Activation Leading to TAU Pathology: Neuro-protection by cAMP. Cell Death & Disease, 3, e326. [Google Scholar] [CrossRef] [PubMed]
[15] Meduri, G., Guillemeau, K., Dounane, O., et al. (2016) Caspa-se-Cleaved Tau-D(421) Is Colocalized with the Immunophilin FKBP52 in the Autophagy-Endolysosomal System of Alzheimer’s Disease Neurons. Neurobiology of Aging, 46, 124-137. [Google Scholar] [CrossRef] [PubMed]
[16] Bednarski, E. and Lynch, G. (1996) Cytosolic Proteoly-sis of Tau by Cathepsin D in Hippocampus Following Suppression of Cathepsins B and L. Journal of Neurochemistry, 67, 1846-1855. [Google Scholar] [CrossRef] [PubMed]
[17] Hamano, T., Gendron, T.F., Causevic, E., et al. (2008) Autophagic-Lysosomal Perturbation Enhances Tau Aggregation in Transfectants with Induced Wild-Type Tau Expres-sion. European Journal of Neuroscience, 27, 1119-1130. [Google Scholar] [CrossRef] [PubMed]
[18] 郑晓燕. “智三针”激活TFEB介导的自噬改善5×FAD小鼠认知功能障碍的研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2021.
[19] Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.P. and Anderton, B.H. (1992) Glycogen Synthase Kinase-3 Induces Alzheimer’s Disease-Like Phosphorylation of Tau: Generation of Paired Helical Filament Epitopes and Neuronal Localisation of the Kinase. Neu-roscience Letters, 147, 58-62. [Google Scholar] [CrossRef] [PubMed]
[20] 肖博雅. 自噬-溶酶体途径损伤在PBDE-47致PC12细胞Aβ病变中的作用[D]: [硕士学位论文]. 武汉: 华中科技大学, 2021.[CrossRef
[21] Kim, S., Lee, D., Song, J.C., et al. (2014) NDP52 Asso-ciates with Phosphorylated Tau in Brains of an Alzheimer Disease Mouse Model. Biochemical and Biophysical Research Communications, 454, 196-201. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, Y., Martinez-Vicente, M., Krüger, U., et al. (2009) Tau Fragmentation, Aggregation and Clearance: The Dual Role of Lysosomal Processing. Human Molecular Genetics, 18, 4153-4170. [Google Scholar] [CrossRef] [PubMed]
[23] Caccamo, A., Magrì, A., Medina, D.X., et al. (2013) mTOR Regulates Tau Phosphorylation and Degradation: Implications for Alzheimer’s Disease and Other Tauopathies. Aging Cell, 12, 370-380. [Google Scholar] [CrossRef] [PubMed]
[24] 丁倩, 张瑾, 马钰泱, 沈玉君, 沈玉先, 冯利杰. 自噬降低异常磷酸化tau蛋白所致的神经细胞毒性[J]. 中国药理学通报, 2017, 33(6): 761-767.
[25] Ozcelik, S., Fraser, G., Castets, P., et al. (2013) Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice. PLOS ONE, 8, e62459. [Google Scholar] [CrossRef] [PubMed]
[26] Lopez, A., Lee, S.E., Wojta, K., et al. (2017) A152T Tau Allele Causes Neurodegeneration That Can Be Ameliorated in a Zebrafish Model by Autophagy In-duction. Brain, 140, 1128-1146. [Google Scholar] [CrossRef] [PubMed]
[27] Chen, J.L., Luo, C., Pu, D., et al. (2019) Metformin Attenuates Diabetes-Induced Tau Hyperphosphorylation in Vitro and in Vivo by Enhancing Autophagic Clearance. Experimental Neurology, 311, 44-56. [Google Scholar] [CrossRef] [PubMed]
[28] Krüger, U., Wang, Y., Kumar, S. and Mandelkow, E.M. (2012) Autophagic Degradation of Tau in Primary Neurons and Its Enhancement by Trehalose. Neurobiology of Aging, 33, 2291-2305. [Google Scholar] [CrossRef] [PubMed]
[29] Ma, Q.L., Zuo, X., Yang, F., et al. (2013) Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice. Journal of Biological Chemistry, 288, 4056-4065. [Google Scholar] [CrossRef
[30] Huuskonen, M.T., Loppi, S., Dhungana, H., et al. (2016) Bexaro-tene Targets Autophagy and Is Protective against Thromboembolic Stroke in Aged Mice with Tauopathy. Scientific Re-ports, 6, Article No. 33176. [Google Scholar] [CrossRef] [PubMed]